Elliott Levy, MD, is a venture partner at 5AM Ventures and senior advisor at Boston Consulting Group. He has deep drug development experience from roles at Bristol Myers Squibb and Amgen, and serves on Terray Therapeutics' Scientific Advisory Board.
At firms with a similar stage, sector and check size.
One email when Elliott's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckElliott Levy, MD, is a venture partner at 5AM Ventures and senior advisor at Boston Consulting Group. He has deep drug development experience from roles at Bristol Myers Squibb and Amgen, and serves on Terray Therapeutics' Scientific Advisory Board.
5AM Ventures has not reported a check size. It invests at seed, series a.
A warm intro from a founder 5AM Ventures backed works best.
senior vice president and head of specialty development at Bristol Myers Squibb; senior vice president of global development at Amgen; Senior Advisor at Boston Consulting Group.
Last updated 2026-10-15. Is this you? Ask for a correction.